Markets News
Stocks1 min read
Medpace Slides 2.84% Ahead of October Earnings Report
The clinical development services provider fell as major indexes rose, with its next earnings report scheduled for October 21.
Key takeaways
- Medpace shares fell 2.84% as the S&P 500 gained 0.58%.
- Medpace is scheduled to report earnings on October 21, 2026.
Medpace shares fell 2.84% to $602.90 on Tuesday afternoon, while the S&P 500 rose 0.58%. The Dow gained 0.49% and the Nasdaq added 0.45%.
The decline came after Medpace had gained 4.94% over the past month, according to the article. That compared with a 4.26% loss for the Medical sector and a 0.84% rise for the S&P 500.
Medpace is scheduled to report earnings on October 21. Zacks consensus estimates call for earnings of $4.45 per share and revenue of $708.75 million for the quarter, up 15.28% and 7.4%, respectively, from a year earlier.
Topics
Further reading
This article was produced with the help of AI technology. Source: Yahoo Finance
